Rivaroksaban Zentiva 20 mg filmom obložene tablete
Name | Rivaroksaban Zentiva 20 mg filmom obložene tablete |
---|---|
Marketing Authorisation Number | HR-H-753253248 |
Active Substance | rivaroksaban |
Composition | jedna filmom obložena tableta sadrži 20 mg rivaroksabana |
Pharmaceutical Form | Filmom obložena tableta |
Packaging [MA Number for Packaging] | 10 tableta u blisteru, u kutiji [HR-H-753253248-01] 14 tableta u blisteru, u kutiji [HR-H-753253248-02] 28 tableta u blisteru, u kutiji [HR-H-753253248-03] 30 tableta u blisteru, u kutiji [HR-H-753253248-04] 50 tableta u blisteru, u kutiji [HR-H-753253248-05] 98 tableta u blisteru, u kutiji [HR-H-753253248-06] 100 tableta u blisteru, u kutiji [HR-H-753253248-07] |
Manufacturer | Zentiva S.A., Bukurešt, Rumunjska
Pharmadox Healthcare Limited, Paola, Malta |
Marketing Authorisation Holder | Zentiva k.s., U Kabelovny 130, Dolni Mecholupy, Prag 10, Češka |
Marketing Authorisation Date | 15.12.2023 |
MA Period of Validity | 15.12.2028 |
Classification Number | UP/I-530-09/23-01/223 |
Registration Number | 381-12-01/70-23-06 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | B01AF01 |
SmPC | download |
PL | download |
Public Assessment Report | download |
Educational materials for healthcare professionals |
Vodič za liječnike s informacijama o primjeni rivaroksabana, verzija 1 |